Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Myriad Genetics Inc (NQ: MYGN )

26.71 USD +0.91 (+3.53%)
Official Closing Price Updated: 4:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Myriad Genetics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
From GlobeNewswire News Releases
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
Focus on Women’s Health, Oncology, Mental Health to Improve Execution and Accelerate Growth 
From GlobeNewswire News Releases
Myriad Genetics CEO Paul J. Diaz to Present at 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene Mutations
From GlobeNewswire News Releases
IPM Launches Innovative Program for Rheumatoid Arthritis
Integrated Prescription Management (IPM), a leading pharmacy benefits management (PBM) company, has signed a contract with Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and... 
From PR Newswire
Suffering in Silence: Two-Thirds of Older Adults Say They Won’t Treat Their Depression
New nationwide poll shows 1 in 3 respondents age 65+ think they can just “snap out of it” 
From GlobeNewswire News Releases
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China
From GlobeNewswire News Releases
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
From GlobeNewswire News Releases
New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis
From GlobeNewswire News Releases
Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
From GlobeNewswire News Releases
Myriad Genetics to Announce Quarterly Financial Results on November 9, 2020
From GlobeNewswire News Releases
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of Stakeholder Interests
From GlobeNewswire News Releases
Myriad Genetics and Sandstone Diagnostics Form Point-of-Care Blood Collection Partnership
Tags business/economy c:united/kingdom h:worldnews
From EIN Presswire
Myriad Genetics Expands Board of Directors with New Member
Rashmi Kumar Elected to Myriad’s Board of Directors 
From GlobeNewswire News Releases
American Society of Clinical Oncology Exclusively Cites myChoice® CDx in New Recommendations for Patients with Advanced Ovarian Cancer
From GlobeNewswire News Releases
Myriad Genetics Announces Inducement Awards
From GlobeNewswire News Releases
Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors
From GlobeNewswire News Releases
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
From GlobeNewswire News Releases
New Study Shows Screening Based on Self-Reported Ethnicity Fails to Identify Significant Percentage of Pregnancies Affected by Serious Genetic Conditions
From GlobeNewswire News Releases
Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020
From GlobeNewswire News Releases
Medicare Expands Coverage for BRACAnalysis® CDx in Prostate Cancer
From GlobeNewswire News Releases
Expected Growth in Cancer Cases Reinforces Need for Superior Diagnostic Options
FinancialBuzz.com News Commentary 
From PR Newswire
Myriad Launches Proprietary AMPLIFY™ Technology, Further Increasing the Performance of its Prequel™ NIPS Test
From GlobeNewswire News Releases
Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra®
From GlobeNewswire News Releases
Myriad Genetics Expands Board of Directors with New Member and Announces Upcoming Retirement of Walter (Wally) Gilbert, Ph.D.
From GlobeNewswire News Releases
Inmedix welcomes Bernie Tobin, former President of Crescendo Bioscience (Myriad Genetics) to its Board of Directors
Tags business/economy h:worldnews banking/finance/investment
From EIN Presswire
Myriad Announces New Studies Validating the Ability of Myriad’s riskScore® Test to Modify Breast Cancer Risk Prediction
Publications Demonstrate the Ability of the PRS Component of riskScore® to Accurately Stratify Breast Cancer Risk in Women Both With and Without Pathogenic Mutations 
From GlobeNewswire News Releases
Myriad Announces Partnership with OptraHEALTH® to Deliver “Gene™” a New AI Based Information Tool for Hereditary Cancer Patients
From GlobeNewswire News Releases
Myriad Launches New GeneSight® Psychotropic Patient Collection Kit
Clinicians Seeing Patients Remotely Can Now Offer Home DNA Sample Collection 
From GlobeNewswire News Releases
New Study Demonstrates the Ability of myPath® Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological Assessment
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.